- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Nl2xKEmvRWk
Arabic Language version of this lecture is available at:
https://youtu.be/K14fWBNdEco
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/e7Ttp4VH0VI
Arabic Language version of this lecture is available at: https://youtu.be/7d5JkPPdHsU
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Ed5naxEDwnQ
Arabic Language version of this lecture is available at:
https://youtu.be/eYe0ORMdnaI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/GaapP5vsLB0
Arabic Language version of this lecture is available at: https://youtu.be/L5ynJVpaPNM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/e7Ttp4VH0VI
Arabic Language version of this lecture is available at: https://youtu.be/7d5JkPPdHsU
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Ed5naxEDwnQ
Arabic Language version of this lecture is available at:
https://youtu.be/eYe0ORMdnaI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/GaapP5vsLB0
Arabic Language version of this lecture is available at: https://youtu.be/L5ynJVpaPNM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/XRD-QqGFP18
- Arabic version of this lecture is available at:
https://youtu.be/c9PoavAtNKM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/0tIlVJEyNOk
Arabic Language version of this lecture is available at: https://youtu.be/2QT68lgSDCM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/_Efu52kZRS4
- Arabic version of this lecture is available at: https://youtu.be/8eGHpjQIy3I
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/JQllk5Ad07E
Arabic Language version of this lecture is available at:
https://youtu.be/KXlJoMDi3ko
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/71ud0njUrFc
Arabic Language version of this lecture is available at:
https://youtu.be/s8dQwB76bFM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/_i1H_i3tOuw
Arabic Language version of this lecture is available at:
https://youtu.be/SYmZ9CmmN5g
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadNephroTube - Dr.Gawad
- English version of this lecture is available at:
https://youtu.be/zrFm0hAZk2A
- Arabic version of this lecture is available at:
https://youtu.be/M_BV8WJVbx0
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/XRD-QqGFP18
- Arabic version of this lecture is available at:
https://youtu.be/c9PoavAtNKM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/0tIlVJEyNOk
Arabic Language version of this lecture is available at: https://youtu.be/2QT68lgSDCM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/_Efu52kZRS4
- Arabic version of this lecture is available at: https://youtu.be/8eGHpjQIy3I
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/JQllk5Ad07E
Arabic Language version of this lecture is available at:
https://youtu.be/KXlJoMDi3ko
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/71ud0njUrFc
Arabic Language version of this lecture is available at:
https://youtu.be/s8dQwB76bFM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/_i1H_i3tOuw
Arabic Language version of this lecture is available at:
https://youtu.be/SYmZ9CmmN5g
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadNephroTube - Dr.Gawad
- English version of this lecture is available at:
https://youtu.be/zrFm0hAZk2A
- Arabic version of this lecture is available at:
https://youtu.be/M_BV8WJVbx0
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Eletro Stimulation of Lower Esophageal Sphincter on GERD treatment Manoel Galvao Neto
First in man Studies in a novel, unique and disruptive technology to surgicaly treat Reflux desease (GERD) without anatomical changes by laparoscopic implant of leads on the esophagi-gastric junction (EGJ) followed by stimulation of a pace=maker
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://youtu.be/gnlRvJ1TTr8
- Video recording of this lecture in Arabic language: https://youtu.be/KdVvfP7JIFI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://www.youtube.com/watch?v=MA7nU5NWL2g&list=PLL7Q08IoVDSpg0VlGdvCHOHbXqMs0GFRe
- Video recording of this lecture in Arabic language: https://www.youtube.com/watch?v=FiWabzTPFqY&list=PLL7Q08IoVDSrVcm6SmppQyefL_Ub2-xGY
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Recorded video of this lecture is available at:
https://youtu.be/4MCu1C5xjvE
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/YT5IlPs6F0I
Arabic Language version of this lecture is available at: https://youtu.be/HUZt4ahXlxo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/V3UGzJTwAWw
- Arabic version of this lecture is available at:
https://youtu.be/hGLaUde2ue4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/t7N2GSXhYwA
- Arabic version of this lecture is available at:
https://youtu.be/WzFZym9hDtQ
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
- English version of this lecture is available at:
https://youtu.be/qItQlXUC2-Q
- Arabic version of this lecture is available at:
https://youtu.be/goKWRFbA4uc
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version video of this lecture is available at:
https://youtu.be/z9P_1IiFR5I
- Arabic version video of this lecture is available at:
https://youtu.be/qmDeWgsAY9Q
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/lvcXwE0fb-w
- Arabic version of this lecture is available at:
https://youtu.be/r-fG8bSCqZo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/WHu05hmExBY
- Arabic version of this lecture is available at: https://youtu.be/GIvZjcq2Eis
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/kanEHVsStsI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/h3HRvWGUj5A
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Hyponatremia (Practical Approach) - Dr. Gawad
1. Hyponatremia
Practical Approach
Mohammed Abdel Gawad
Nephrology Consultant - Alexandria - Egypt
MD Nephrology - Mansoura University
European Specialty Examination in Nephrology (ESENeph)
NephroTube Founder/Admin
Member of ISN education SoMe team
Co-chair of AFRAN Web & Media Committee
drgawad@gmail.com
@Gawad_Nephro
NephroTube Webinar, 01-July-2021
2. To download the lecture contact me
drgawad@gmail.com
For more Nephrology lectures visit
www.NephroTube.com
5. Normal serum sodium
135-145 mEq/L (mmol/L)
Hyponatremia serum sodium
< 135 mEq/L (mmol/L)
the most common disorder of body fluid and
electrolyte balance encountered in clinical practice
• Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Clinical Endocrinology 2007 66 367–372
• Upadhyay A, Jaber BL, Madias NE. Seminars in Nephrology 2009 29 227–238
7. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Hyponatremia is primarily a
disorder of water balance
Relative excess of body water compared to
total body sodium and potassium content
H2O > Na
10. Hyponatremia
Clinical Presentation
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
The presence of these symptoms and their severity depend
on both the MAGNITUDE of the hyponatremia and the
RATE at which the hyponatremia developed
11. Hyponatremia
Pathogenesis of Central Effect
M.Gawad www.nephrotubecne.com
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Normally: ICF Osmolality = ECF Osmolality
Intracellular Extracellular
15. Hyponatremia
How brain adapt hyponatremia ??
(especially chronic cases)
Maximal compensation for a
decrease in plasma osmolality
typically requires up to
48 hours.
Adrogue HJ & Madias NE. Hyponatremia. NEJM 2000 342 1581–1589.
Avoid rapid correction of
hyponatremia
18. Repeat serum Na
The level should be repeated to rule out:
– Lab error.
– blood-drawing error.
Precautions of sample taking:
– the blood should be drawn through the
skin (not from an IV line).
– the blood should be drawn from a vein that
does not have IV fluids flowing through it.
20. What is the next step?
What is the relation between
Na and Plasma Osmolality?
Normally ranges between 275 and 295 mmol/L
21. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders,
5th ed, McGraw-Hill, New York 2001. p.699.
Translocational
22. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders,
5th ed, McGraw-Hill, New York 2001. p.699.
Exclude Pseudo &
Translocational Hyponatremia
Translocational
23. True vs Pseudo - Hyponatremia
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
24. In which compartment of the following we are
measuring sodium concentration ??
Blood
5 liters
Plasma
55%, 3 liters
Water 90%
Lipids, proteins &
other inorganic
substances
Cellular
elements
45%, 2 liters
RBCs WBCs Platelets
Pseudohyponatremia
(Normal Plasma Osmolality)
Introduction
25. TAKE CARE it is:
Na CONCENTRATION, Not Na LEVEL
Pseudohyponatremia
(Normal Plasma Osmolality)
Introduction
28. Water +
Na
Proteins,
Lipids
Cells
Na conc to
water = 50%
Na conc to
plasma =
35% Water +
Na
Proteins,
Lipids
Cells
Na conc to
water = 50%
Na conc to
plasma =
15%
The above numbers are not true values, they are only for demonstration
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
M.Gawad www.nephrotube.com
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
29. The traditional method of measuring the
sodium concentration in plasma flame
photometry uses the entire volume of the
sample, which includes both the aqueous
and nonaqueous phases of plasma.
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
30. Therefore, for patients with marked
elevations in plasma lipids or plasma
proteins, ask the hospital laboratory to use
an ion-specific electrode to measure the
plasma sodium concentration.
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Pseudohyponatraemia still occurs despite
the use of ion-selective electrodes
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
31. Serum Na x 93
99 – 1.03 (triglyceride gm/L) – 0.73 (protein gm/L)
Corrected Na =
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Stephen Sigworth, MD, MSHA. Sodium Disorders
32. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders,
5th ed, McGraw-Hill, New York 2001. p.699.
Translocational
33. Translocational- Hyponatremia
(High Plasma Osmolality)
High Serum Glucose or
Hypertonic Infusions
•Carlotti AP et al. Intensive Care Medicine 2001 27 921–924
•Oster JR et al. Archives of Internal Medicine 1999 159 333–336
•Hillier TA et al. American Journal of Medicine 1999 106 399–403
Translocational
34. Translocational Hyponatremia
(High Plasma Osmolality)
Here Na is truly low
(i.e. not lab error),
but
plasma osmolality is high
Handbook of Critical Care Nephrology. Chapter 19. 2021
Carlotti AP et al. Intensive Care Medicine 2001 27 921–924
Hypertonic
Infusions
Adjusted sodium = Na + 1.6 × (glucose/100)
35. How to differentiate between 3 types
of hyponatremia?
Logic = Measure Plasma Osmolality
Translocational
38. Repeat serum Na
Exclude Drugs
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
39. Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
40. Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
41. Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
42. H2O > Na
True Hyponatremia Cause?
Adrogue HJ, Madias NE. Clinical Endocrinology 2000 52 667–678
5
43. Hoorn EJ et al. QJM: Monthly Journal of the Association of Physicians 2005 98 529–540
True Hyponatremia Cause?
5
44. Clinical assessment of volume status ?!
Generally not very accurate
Likely to lead to misclassification of hyponatraemia
Low sensitivity (0.5–0.8) and specificity (0.3–0.5)
Algorithms that start with a clinical
assessment of volume status are not accurate
Hoorn EJ et al. QJM: Monthly Journal of the Association of Physicians 2005 98 529–540
True Hyponatremia Cause?
5
45. Start with urine osmolality
and sodium concentration
(best determined in the same urine
sample)
Use the terms:
a- Effective circulating volume
b- Extracellular fluid volume
Instead of hyper, hypo,
euo - volumic
46. This diagnostic tree is a simplification and
does not guarantee completeness in each
individual
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
5
54. The overwhelming majority of patients in the neurosurgical setting with
hyponatremia after subarachnoid hemorrhage, trauma, or surgery have
SIADH, not CSW
Handbook of Critical Care Nephrology. Chapter 19. 2021
55.
56.
57. Patients who develop hemodynamic instability and frank volume depletion
in response to fluid restriction have CSW, and patients whose urine volume
decreases and sodium improves with fluid restriction have SIADH
Handbook of Critical Care Nephrology. Chapter 19. 2021
59. occasional increase in FEphosphate >20% in RSW
FEphosphate should be
determined before administering saline
Kidney International (2009) 76, 934–938
60. SIADH RSW/CSW
Volume before treatment Euvolemia Hypovolemia
(orthostatic hypotension)
FEphosphate before
administering saline
Normal ± >20%
hemodynamic instability
and frank volume
depletion with fluid
restriction
No Yes
After correction of
hyponatremia
Kidney International (2009) 76, 934–938
61. Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
65. General rules – 0.9% or 3% NaCl infusion
Maximum correction limit (i.e. Stop infusion when)
10 mmol/l in the
first 24 h
8 mmol/l during
every 24 h
thereafter
130 mmol/l is
reached or
serum sodium
concentration
increases
10 mmol/l in
total
symptoms
improved
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
66. General rules – 0.9% or 3% NaCl infusion
Maximum correction limit (i.e. Stop infusion when)
10 mmol/l in the
first 24 h
8 mmol/l during
every 24 h
thereafter
130 mmol/l is
reached or
serum sodium
concentration
increases
10 mmol/l in
total
symptoms
improved
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
If the symptoms still have not improved, it is unlikely that
the symptoms are due to the hyponatremia and
alternative explanations should be sought
Handbook of Critical Care Nephrology. Chapter 19. 2021
68. Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Total Body Water Assessment (TBW)
men <70 years old 0.6 × body weight
men ≥70 years old
women <70 years old
0.5 × body weight
women ≥70 years old 0.45 × body weight
69. Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Keep in mind that if hypokalaemia is
present, correction of the hypokalaemia
will contribute to an increase in serum
sodium concentration.
Kamel KS, Bear RA. Am J Kidney Dis. 1993;21(4):439.
70. Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Keep in mind that if hypokalaemia is
present, correction of the hypokalaemia
will contribute to an increase in serum
sodium concentration.
Kamel KS, Bear RA. Am J Kidney Dis. 1993;21(4):439.
Case Rep Nephrol. 2017; 2017: 4521319
79. Management – Severe Symptoms
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
Maximum:
Repeat twice
Maximum:
5 mmol/l
increase
A. Improvement of
symptoms
→ Stop 3% infusion
B. No improvement
of symptoms
→ continue infusion
targeting general
rules of raising
serum Na
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
keep the i.v. line
open by infusing the
smallest feasible
volume of 0.9%
saline until cause-
specific treatment is
started
First-hour management:
81. Management – Moderate Symptoms
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
A. Improvement of
symptoms
→ Stop 3% infusion
B. No improvement
of symptoms
→ continue infusion
targeting general
rules of raising
serum Na
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
keep the i.v. line
open by infusing the
smallest feasible
volume of 0.9%
saline until cause-
specific treatment is
started
83. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Acute presentation
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
If the acute decrease in serum sodium concentration exceeds 10 mmol/l
89. • Increased number of deaths in those patients treated with
vasopressin receptor antagonists in comparison with those treated
with placebo.
• Vasopressin receptor antagonists may actually worsen outcomes.
• Rozen-Zvi B et al. American Journal of Kidney Diseases 2010 56 325–337
• Jaber BL et al. American Journal of Medicine 2011 124 971–979
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
JAMA. 2007;297(12):1319-1331
90. • Increased number of deaths in those patients treated with
vasopressin receptor antagonists in comparison with those treated
with placebo.
• Vasopressin receptor antagonists may actually worsen outcomes.
• Rozen-Zvi B et al. American Journal of Kidney Diseases 2010 56 325–337
• Jaber BL et al. American Journal of Medicine 2011 124 971–979
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Heart Faliure: ADH receptor antagonists, either intravenous (IV) conivaptan
or oral tolvaptan, would be appropriate agents to increase serum sodium
although they have not been shown to improve heart failure outcomes
JAMA. 2007;297(12):1319-1331
91. The side effects reported for demeclocycline and lithium were
such that we recommend not using them for any degree of
hyponatraemia.
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
100. Rapid Correction of Hyponatremia
Bad Effect
Rare but dramatic complication
Osmotic demyelination syndrome
Rapid correction of Na
=
Rapid increase in plasma
osmolality
Rapid shift of
water form
intracellular
space
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
101. Handbook of Critical Care Nephrology. Chapter 19. 2021
Consideration should be given to correcting the sodium even
slower
102. Handbook of Critical Care Nephrology. Chapter 19. 2021
Consideration should be given to correcting the sodium even
slower
In some situations, specific treatments of hyponatremia are so
effective that patients will autocorrect their hyponatremia faster
than 8 mmol/L/d
• psychogenic polydipsia
• tea and toast syndrome
• volume depletion
• thiazide-induced hyponatremia
• adrenal insufficiency
103. Cases of ODS despite guideline-based
correction speeds have been reported
Eur J Endocrinol. 2014;170(3):G1-G47.
Cureus. 2020;12(1):e6547.
104. Rapid Correction of Hyponatremia
Bad Effect
Rare but dramatic complication
Osmotic demyelination syndrome
Diagnosis:
The lesions are detectable by both CT scan and MRI. MRI is
more sensitive (because it is better able to visualize the brain
stem and is more sensitive to changes in the white matter).
Timing is critical in diagnostic studies because lesions do not
become apparent for up to four weeks. Because of this delay,
an initially negative study does not rule out.
Harring TR, Deal NS, Kuo DC. Emerg Med Clin North Am. 2014 May;32(2):379-401.
105. Rapid Correction of Hyponatremia
What to do?
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
If increases >10 mmol/l during the first 24 h or >8 mmol/l in
any 24 h thereafter
Discontinuing the ongoing
active treatment (1D).
Consulting an expert to
discuss if it is appropriate to
start an infusion of 10 ml/kg
body weight of electrolyte-
free water (e.g. glucose
solutions) over 1 h under
strict monitoring of urine
output and fluid balance (1D).
Consulting an expert to
discuss if it is appropriate to
add i.v. desmopressin 2 μg,
with the understanding that
this should not be repeated
more frequently than every
8h (1D).
106. A more proactive approach is to start DDAVP at the outset of the
treatment of hyponatremia; this is called a DDAVP clamp
Rapid Correction of Hyponatremia
How to avoid?
Handbook of Critical Care Nephrology. Chapter 19. 2021
109. Hyponatremia in a Patient on Hemodialysis
How to Manage?
Plasma Na level
of the patient
Daugirdas, JT, Ross, et al. Acute hemodialysis Prescription. In:
Handbook of Dialysis, Philadelphia 2007
Dialysate sodium
concentration
Maximum difference
15-20 mEq
110. Hyponatremia in a Patient on Hemodialysis
How to Manage?
Concurrent infusions
of 5 % dextrose
(D5W)
Every 1L of D5W will
decrease serum
sodium concentration
by 3.5 mEq / L
Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342(20):1493-1499.
111. CRRT may also be used to safely correct hyponatremia.
CRRT is less efficient in the rate at which serum sodium is
changed and results in a more gradual correction over a
longer time span
Am J Kidney Dis. 2014;64:305.
Hyponatremia in a Patient on Hemodialysis
How to Manage?
112. Uremia may provide some protection against
osmotic demyelination
Rapid correction of Na
=
Rapid increase in plasma
osmolality
High
intracellular
urea level
114. The presence of symptoms and their severity depend on
both the MAGNITUDE of the hyponatremia and the
RATE at which the hyponatremia developed
Home Messages
115. Normal Maximal compensation for a decrease in plasma
osmolality typically requires up to 48 hours.
Avoid rapid correction of hyponatremia
Home Messages
116. 3% NaCl infusion is mandatory in:
- Severe symptoms
- Moderate symptoms
- Acute presentation
Home Messages
117. Uremia may provide some protection against
osmotic demyelination
Home Messages